17 research outputs found
Avian response to early tidal salt marsh restoration at former commercial salt evaporation ponds in San Francisco Bay, California, USA
Restoration of former commercial salt evaporation ponds in the San Francisco Bay estuary is intended to reverse a severe decline (\u3e79%) in tidal salt marshes. San Francisco Bay is a critical migratory stopover site and wintering area for shorebirds and waterfowl, and salt ponds are important high tide roosting and foraging areas. Conservation of past bird abundance is a stated goal of area restoration projects, and early adaptive management will be critical for achieving this objective. However, initial avian response at sites restored to tidal flow may not be indicative of long-term results. For example, winter shorebirds at a 529 ha pond breached in 2002 showed a marked increase in shorebird abundance following breaching. Shorebirds comprised 1% of area totals during 1999-2002 and increased to 46% during 2003-2008. These changes accompanied increased tidal range and sedimentation, but minimal vegetation establishment. Conversely, a fully vegetated, restored 216 ha pond in the same system consistently supported less than 2% of all waterbirds in the region. Early restoration may temporarily increase habitat, but managed ponds will be needed for long-term waterbird abundance within a restored pond-marsh system
Recommended from our members
Biodistribution of the multidentate hydroxypyridinonate ligand [(14) C]-3,4,3-LI(1,2-HOPO), a potent actinide decorporation agent.
The pharmacokinetics and biodistribution of the (14) C-labeled actinide decorporation agent 3,4,3-LI(1,2-HOPO) were investigated in young adult Swiss Webster mice and Sprague Dawley rats, after intravenous, intraperitoneal, and oral dose administration. In all routes investigated, the radiolabeled compound was rapidly distributed to various tissues and organs of the body. In mice, the 24 h fecal elimination profiles suggested that the biliary route is the predominant route of elimination. In contrast, lower fecal excretion levels were observed in rats. Tissue uptake and retention of the compound did not differ significantly between sexes although some differences were observed in the excretion patterns over time. The male mice eliminated a greater percentage of (14) C through the renal pathway than the female mice after receiving an intravenous or intraperitoneal dose, while the opposite trend was seen in rats that received an intravenous dose. Metabolite profiling performed on selected rat samples demonstrated that a putative major metabolite of [(14) C]-3,4,3-LI(1,2-HOPO) is formed, accounting for approximately 10% of an administered oral dose. Finally, to improve its oral bioavailability, 3,4,3-LI(1,2-HOPO) was coformulated with a proprietary permeability enhancer, leading to a notable increase in oral bioavailability of the compound